亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effect of age and gender in rates of achieving minimal clinically important difference and patient‐acceptable symptom state 2 years after arthroscopic superior capsular reconstruction

医学 外科 物理疗法
作者
Hui Ben,Ji Woong Yeom,Erica Kholinne,Jia Guo,Ji Yeon Park,Seung Min Ryu,Kyoung Hwan Koh,In‐Ho Jeon
出处
期刊:Knee Surgery, Sports Traumatology, Arthroscopy [Springer Science+Business Media]
卷期号:32 (4): 1038-1048 被引量:11
标识
DOI:10.1002/ksa.12128
摘要

PURPOSE: This study aimed to evaluate patient-reported outcome measures (PROMs) and the effects of gender and age on achieving clinically significant outcomes in patients undergoing arthroscopic superior capsular reconstruction (ASCR) with a minimum 2-year follow-up. METHODS: Patients undergoing ASCR for irreparable rotator cuff tear between 2013 and 2020 were reviewed. Preoperative and minimum 2-year postoperative PROMs were collected, including American Shoulder and Elbow Surgeons (ASES), Constant, single assessment numeric evaluation (SANE), and visual analog scale (VAS) scores. Minimal clinically important difference (MCID) and patient-acceptable symptomatic state (PASS) were calculated for each functional score and analyzed according to age and gender. The percentages of patients achieving MCID and PASS were recorded. RESULTS: The study included 83 patients, with a mean follow-up of 3.5 ± 1.4 years. Significant improvements were found in ASES, Constant, SANE, and VAS for all groups based on gender and age. Based on receiver-operating characteristic curves, all scores had acceptable areas under the curve for PASS. Values for PASS and MCID were 81.5 and 10.3 for ASES; 61.5 and 6.2 for Constant; 82.5 and 11.5 for SANE and 1.5 and 1.1 for VAS, respectively. Analysis of achieving MCID and PASS showed no difference between the groups in the majority of outcome measures. However, female patients achieved the SANE thresholds for PASS at significantly higher rates than male patients. Patients ≥65 years old achieved ASES and Constant thresholds for MCID at significantly higher rates than patients ˂65 years old. CONCLUSION: Most patients achieved MCID and PASS at a 2-year follow-up. Patients showed comparable rates of MCID and PASS achievement on most outcome tools based on age and gender. Female patients achieved PASS on SANE at significantly higher rates than male patients and older patients achieved MCID on ASES and Constant at higher rates than young patients. Thus, age is a stronger factor for achieving MCID than gender. LEVEL OF EVIDENCE: Level II.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被纯情的阁采纳,获得10
4秒前
老实的石头完成签到,获得积分10
12秒前
霸气祥完成签到,获得积分10
12秒前
超帅的半莲完成签到,获得积分10
12秒前
23秒前
369ninja发布了新的文献求助10
29秒前
null的应助被纯情的阁采纳,获得10
39秒前
null的应助被纯情的阁采纳,获得10
39秒前
fairytaler的应助被纯情的阁采纳,获得10
39秒前
39秒前
范特西完成签到 ,获得积分10
50秒前
53秒前
缓慢的雨筠完成签到,获得积分10
57秒前
幽默的萍完成签到,获得积分10
1分钟前
1分钟前
爱笑美女完成签到,获得积分10
1分钟前
犹豫擎苍完成签到,获得积分10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
1分钟前
madeleinli的应助被纯情的阁采纳,获得10
2分钟前
慕青的应助被纯情的阁采纳,获得10
2分钟前
madeleinli的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
小蘑菇的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
2分钟前
单纯冰菱完成签到,获得积分10
2分钟前
2分钟前
火星上的山柳完成签到,获得积分10
2分钟前
2分钟前
大个的应助被Eva小飞鱼采纳,获得10
2分钟前
称心的忆山完成签到,获得积分10
2分钟前
2分钟前
agathahqs的应助被纯情的阁采纳,获得30
3分钟前
agathahqs的应助被纯情的阁采纳,获得10
3分钟前
agathahqs的应助被纯情的阁采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158827
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552000
邀请新用户注册赠送积分活动 2471370